The Evolving Roles of Human iPSC-Derived Cardiomyocytes in Drug Safety and Discovery

被引：65
|
作者：
Gintant, Gary [1 ]
Fermini, Bernard [2 ]
Stockbridge, Norman [3 ]
Strauss, David [4 ]
机构：
[1] AbbVie, Integrated Sci & Technol, Dept Integrat Pharmacol ZR13, Bldg AP-9A LL,1 North Waukegan Rd, N Chicago, IL 60064 USA
[2] Coyne Sci, 58 Edgewood Ave NE, Atlanta, GA 30303 USA
[3] US FDA, Ctr Drug Evaluat & Res, Div Cardiovasc & Renal Prod, Silver Spring, MD 20993 USA
[4] US FDA, Ctr Drug Evaluat & Res, Div Appl Regulatory Sci, Silver Spring, MD 20993 USA
来源：
CELL STEM CELL | 2017年 / 21卷 / 01期
关键词：
CARDIOTOXICITY;
D O I：
10.1016/j.stem.2017.06.005
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Nonclinical studies of drug effects with human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) provide new possibilities for evaluating drug safety and efficacy. The Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm provides lessons from the cardiac field that also apply to drug studies with other stem cell-based assays.
引用
收藏
页码：14 / 17
页数：4
相关论文
共 50 条
  • [1] iPSC-Derived Human Cardiomyocytes
    Anson, Blake
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (10): : 18 - 19
  • [2] Human iPSC-Derived Cardiomyocytes
    Salvagiotto, Giorgio
    Sirenko, Oksana
    Hesley, Jayne
    Kattman, Steven
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2012, 32 (08): : 28 - 29
  • [3] A new suite of media for cardiotoxicity and drug discovery studies with human iPSC-derived cardiomyocytes
    Filali, O.
    Armstrong, A.
    Livingston, M.
    Carlson, C.
    Rieger, C.
    Meyer, N.
    Vaidyanathan, R.
    Rajesh, D.
    TOXICOLOGY LETTERS, 2022, 368 : S75 - S75
  • [4] Industrialized Production of Human iPSC-Derived Cardiomyocytes for Use in Drug Discovery and Toxicity Testing
    Anson, Blake
    Nuwaysir, Emile
    Swanson, Brad
    Wang, Wen Bo
    BIOPHARM INTERNATIONAL, 2011, 24 (03) : 58 - +
  • [5] iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
    Simons, Eline
    Loeys, Bart
    Alaerts, Maaike
    BIOMEDICINES, 2023, 11 (02)
  • [6] TRANSCRIPTOMIC CHARACTERIZATION OF HUMAN IPSC-DERIVED CARDIOMYOCYTES
    Gomes-Silva, Beatriz
    Ribeiro, Marta
    Furtado, Marta
    Martins, Sandra
    Carvalho, Teresa
    Barbosa, Pedro
    Savisaar, Rosina
    Carmo-Fonseca, Maria
    MEDICINE, 2022, 101 (30)
  • [7] Assessment of mitophagy in human iPSC-derived cardiomyocytes
    Yang, Mingchong
    Fu, Ji-Dong
    Zou, Jizhong
    Sridharan, Divya
    Zhao, Ming-Tao
    Singh, Harpreet
    Krigman, Judith
    Khan, Mahmood
    Xin, Gang
    Sun, Nuo
    AUTOPHAGY, 2022, 18 (10) : 2481 - 2494
  • [8] Maturing iPSC-Derived Cardiomyocytes
    Tang, Bor Luen
    CELLS, 2020, 9 (01)
  • [9] Differentiation and validation of human iPSC-derived atrial cardiomyocytes
    Sutton, Kathy
    El Haou, Said
    Williams, Sarah
    Devalla, Harsha
    Stoelzle-Feix, Sonja
    Juhasz, Krisztina
    Doerr, Leo
    Beckler, Matthias
    Haarmann, Claudia
    George, Michael
    Passier, Robert
    Fertig, Niels
    Rogers, Marc
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 168 - 168
  • [10] Imaging cAMP nanodomains in human iPSC-derived cardiomyocytes
    Charriere, Camille
    NATURE REVIEWS CARDIOLOGY, 2024, 21 (07) : 441 - 441
12345